Select Page

Membership

Latest Members

Medicon Valley Alliance is continually adding new life science companies and organisations as members.

These companies and organisations have decided to join forces and strengthen their ties within the region, thereby anhancing their visibility with national and international companies looking at life science in Medicon Valley.

Below is a list of the companies that have most recently joined the Medicon Valley Alliance!

Take a look and see if one of them is your new business partner. If you wish to view a directory of all companies and organisations in Medicon Valley – click here!

CRS CLINICAL RESEARCH SERVICES

Your clinical research partner with a remarkable track record

CRS is one of Europe’s leading clinical research institutes for Early clinical phase, from First-in-Human to Proof-of-Concept studies in patients. We have over 40 years of experience in conducting Early clinical research studies, with specific expertise in the field of Cardiometabolic, NASH, Respiratory, Dermatology, Woman and Men´s health as well as in conducting clinical trials in Renal and Hepatic impaired patients.

With three clinical research units in the largest metropolitan regions of Germany and a total capacity of 200 in-house beds, CRS offers Pharmaceutical, Biotech and Medtech companies, innovative solutions in trial design and an outstanding experience in conducting clinical studies.

Warmly welcome to contact us to learn more and to discuss how we can assist you in the successful clinical development of your program. Ulrika Mårtensson PhD, Director Business Development, ulrika.martensson@crs-group.de

You find more information about CRS and our capabilities by visiting our website at the following link: www.crs-group.de

 

 

Acolad Life Sciences

Acolad Life Sciences is the division within Acolad dedicated to certified language solutions for Pharma, Medical devices, Medtech and Clinical Research Organizations. Supported by the unmatched expertise of its medical translators and technology-driven language solutions, Acolad Life Sciences partners with its clients through every stage of product development – from clinical trials to post-market surveillance – ensuring adherence to industry standards and regulatory requirements of national and international health authorities worldwide.

Make Believe

Make Believe is a strategic storytelling partner to the leading organisations in the healthcare sector.

Our unique approach combines profound actionable insights with captivating storytelling, taking the complex world of science into an emotive and directional narrative. This in turn, triggers transformative shifts in behavior and positive commercial outcomes.

Since our inception in 2004, our passion has been to craft stories that not only inform but also move people to action. We pride ourselves on transforming your audience into ardent believers.

Our storytelling canvas spans four distinct domains:

  • Brand: We breathe life into your brand, weaving narratives that embody authenticity and purpose.
  • Science: Complex scientific concepts find clarity and engagement through our storytelling magic.
  • Value: We bring out the intrinsic value of your offerings and create actionable content to help affiliates inspire your payer audience.
  • Culture: We distil the essence of your organisation’s culture, fostering a shared purpose and facilitating change.

At Make Believe, we harness the power of emotion to guide your audience towards meaningful and actionable outcomes. Together, we can bring your vision to life in the most inspiring and impactful way.

Reach out to Arpad Maksay at arpad@makebelieveuk.com or on +4560213269 to start a conversation.

BaseClear

The more we uncover about the microbial world, the more we realise there’s much more to discover. We are on the verge of truly understanding the role of microbes in health, disease, nutrition, and the environment. BaseClear is actively cooperating with other experts to identify, characterise and analyse many novel microbial strains for a wide range of applications. As a part of our mission in accelerating the understanding and use of microorganisms for a more sustainable, safer and healthier future, BaseClear is a leading partner in microbial genomics research.

Over the last three decades we have built considerable experience and expertise in microbial genomics. BaseClear offers a complete range of microbial genomics services including: metagenomics, microbiome analysis and microbial strain characterisation for regulatory approval. We are the preferred partner for many leading brands in various industries such as food, food ingredients, pharma, cosmetics, and animal health in Europe and beyond. We are proudly located in the heart of the Leiden Bio Science Park, a leading biomedical hotspot in Europe. With a Business Developer based in Copenhagen since 2023, we are now equipped to build even stronger relationships with companies across the Scandinavian market and provide them with cutting-edge services.

Fareva

Fareva is a family owned french CDMO, the largest one in France and employs more than13,000 people globally, distributed in 41 production sites located in 13 countries in EMEA and the Americas.

18 of the Fareva sites (including the latest acquisitions) are dedicated to pharmaceutical activities. We have industry leading capabilities in development & manufacturing of a large range of Drug Products and Active Pharmaceutical Ingredients (APIs).

Fareva capabilities support a broad range of therapeutic areas including vaccines, oncology, antibiotics, biologics, OTC, animal health and ophthalmic products.

Fareva’s API division has operations in 3 European sites located in France and Germany and these sites are EMA and US-FDA inspected, specialising in development & optimisation of complex, multi-step synthesis of APIs & Advanced Intermediates. The group has niche technologies for high potent APIs (HPAPIs) down to the OEB-6 level, aseptic crystallization (sterile APIs), Spray Drying etc, with volumes ranging from a few kgs to multi tons production. FAREVA is also the first and only company in the world to receive SafeBridge Certification to handle both high potent drug substance and drug product at the same facility. Link to more info on the website- https://www.fareva.com/en/our-sectors/api

Fareva’s Drug Product division offers different technologies: injectables (lyophilized, solution, suspension, vial, ampoules, pre-filled syringes), unidoses and multidoses BFS, solids (tablets, hard capsules, powders), semi-solids (cream, gel suppositories) and liquids (oral and external, sprays, aerosols). And can fill into wide range of presentations (vials, pre-filled syringe, cartridges, unidose and multidose BFS, bottles, tubes, sachet, suppositories, blisters etc.) assist in tech transfer activities to facilitate smooth integration into our facility.

Link to more info on the website – https://www.fareva.com/en/our-sectors/pharmaceuticals

We are able to support our customers from early clinical phase programs, requiring small scale manufacturing, process optimisation and scale-up, to launch and commercial phases.

All sites are state of the art cGMP and accredited by several international pharmaceutical agencies such as FDA, ANVISA, Russia, Japan, China and others.

Evnia

Evnia is a Medical Device and In-Vitro Diagnostics (IVD) Regulatory and Clinical affairs specialist organisation.

Our goal is to help manufacturers accelerate innovation and maintain devices in the European market through reliable regulatory and clinical strategy and implementation under EU/MDR and EU/IVDR.

Evnia has until to date, completed more than 430 clinical evaluation reports (CERs) and supporting technical files, 235 PMCF plans and activities, 92 Regulatory affairs management activities and 80+ Real World Evidence (RWE) activities. We support and trusted by 135 legal manufacturers around the world.

We provide scalable solutions and services for any product portfolios big and small.

Reccan

Reccan, a young medtech company dedicated to improving the prognosis for patients diagnosed with pancreatic cancer. We are working to change the trajectory of pancreatic cancer mortality by finding the cancer at an earlier stage than today. We are developing an easy-to-use blood test for early detection of pancreatic cancer. The lack of diagnostic biomarkers and limitations with the gold standard tumour marker CA19-9 led the way to the exploration of tumour biology and biomarkers in pancreatic cancer tissue leading up to the founding of Reccan by clinicians and researchers at the Lund University Hospital.

CIBT / Blair Consular

CIBT / Blair Consular, an industry leader with over 50 years of experience, offers a range of services, including document legalization and authentication, trade advisory, corporate travel, global immigration, and advisory services.

The CIBT Group comprises three pillars, Document Services, Visas & immigration/mobility. CIBTvisas simplifies travel with up-to-date travel requirement information worldwide. Newland Chase serves as an extension of your in-house teams, providing strategic travel, immigration, and compliance advice.

CIBT’s Document Services assists a great deal of the pharma & life science sector with several services:

  • Global Regulatory Document Legalization: Program clients have a dedicated team providing upfront information on process requirements, costs, and processing times.
  • Regulatory Document Submissions: We streamline the preparation of CPP requests and EudraGMDP documents, optimizing submission and processing, saving time and costs.
  • Physical Movement of Documents: Our services cover collecting and submitting documents to local health authorities, printing and delivering documents, managing document logistics overseas, and handling payments on your behalf.

We aim to enhance your attestation, certification, and legalization processes—locally, regionally and globally. We can locally and regionally deliver a one point of contact with a Global hub solution.

Calyx

Through innovative eClinical and regulatory solutions and services, scientific knowledge, and operational expertise, Calyx helps bring new medical treatments to market reliably. Calyx leverages its 30 years of supporting trial sponsors and CROs to solve complex problems, deliver fast insights, and get new drugs to patients every day.

Calyx’s solutions and services have been relied on by the global biopharmaceutical industry in over 60,000 clinical trials to date. Their offerings are structured around three key specialist areas comprising Medical Imaging, tech-enabled Interactive Response Technology (IRT, commonly referred to as RTSM), and Enterprise Technologies which includes a Clinical Trial Management System (CTMS), Regulatory Information Management (RIM) software, and Electronic Data Capture (EDC) software.

HHC Medical

Revolutionizing drug delivery – HHC Medical is a health tech startup developing a platform technology for targeted and non-invasive drug delivery via wireless electroporation. Our groundbreaking platform targets precise areas within the body, making it possible to deliver localized genetic therapies previously deemed unattainable. This revolutionary approach has the potential to redefine the delivery of genetic medicine, unlocking new avenues of patient care on a global scale.